O. YILDIZ Et Al. , "Effectiveness of ombitasvir/paritoprevir/ritonavir dasabuvir ribavirin in hemodialysisi patients with chronic HCV," APASL 2018. 27 th Annual Conference of the Asian Pacific Association for the Study of the Liver , 2018
YILDIZ, O. Et Al. 2018. Effectiveness of ombitasvir/paritoprevir/ritonavir dasabuvir ribavirin in hemodialysisi patients with chronic HCV. APASL 2018. 27 th Annual Conference of the Asian Pacific Association for the Study of the Liver .
YILDIZ, O., AYGEN, B., GÖKAHMETOĞLU, S., BALTACI, S., MUMCU, N., & eren, e., (2018). Effectiveness of ombitasvir/paritoprevir/ritonavir dasabuvir ribavirin in hemodialysisi patients with chronic HCV . APASL 2018. 27 th Annual Conference of the Asian Pacific Association for the Study of the Liver
YILDIZ, ORHAN Et Al. "Effectiveness of ombitasvir/paritoprevir/ritonavir dasabuvir ribavirin in hemodialysisi patients with chronic HCV," APASL 2018. 27 th Annual Conference of the Asian Pacific Association for the Study of the Liver, 2018
YILDIZ, ORHAN Et Al. "Effectiveness of ombitasvir/paritoprevir/ritonavir dasabuvir ribavirin in hemodialysisi patients with chronic HCV." APASL 2018. 27 th Annual Conference of the Asian Pacific Association for the Study of the Liver , 2018
YILDIZ, O. Et Al. (2018) . "Effectiveness of ombitasvir/paritoprevir/ritonavir dasabuvir ribavirin in hemodialysisi patients with chronic HCV." APASL 2018. 27 th Annual Conference of the Asian Pacific Association for the Study of the Liver .
@conferencepaper{conferencepaper, author={ORHAN YILDIZ Et Al. }, title={Effectiveness of ombitasvir/paritoprevir/ritonavir dasabuvir ribavirin in hemodialysisi patients with chronic HCV}, congress name={APASL 2018. 27 th Annual Conference of the Asian Pacific Association for the Study of the Liver}, city={}, country={}, year={2018}}